Predictions
Ladder Capital Corp
Start price
Target price
Perf. (%)
€10.60
25.06.24
25.06.24
€12.14
25.06.25
25.06.25
8.63%
29.07.24
29.07.24
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
25.06.24
25.06.24
€23.35
25.06.25
25.06.25
-
20.03.24
20.03.24
G1 Therapeutics
Start price
Target price
Perf. (%)
€1.94
25.06.24
25.06.24
-
25.06.25
25.06.25
15.14%
06.07.24
06.07.24
Could be worthwhile Investment >10% per year
High dividend yield expected
Bad rating
Lower EBIT Margin than peer group
Savara Inc.
Start price
Target price
Perf. (%)
€3.52
25.06.24
25.06.24
-
25.06.25
25.06.25
14.20%
06.07.24
06.07.24
Business model of the past or high risk
High valuation
Bad rating
Low dividend yield expected
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€60.53
24.06.25
24.06.25
4.18%
16:58
16:58
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€111.85
24.06.25
24.06.25
4.18%
16:58
16:58
Checkpoint Therapeutics
Start price
Target price
Perf. (%)
€0.50
24.06.24
24.06.24
€31.69
24.06.25
24.06.25
-
18.03.23
18.03.23
First Interstate BancSystem Inc
Start price
Target price
Perf. (%)
€24.60
24.06.24
24.06.24
€29.82
24.06.25
24.06.25
16.26%
30.07.24
30.07.24
Levi Strauss & Co.
Start price
Target price
Perf. (%)
€21.69
24.06.24
24.06.24
€26.07
24.06.25
24.06.25
-22.04%
29.07.24
29.07.24
Lexicon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.67
24.06.24
24.06.24
€9.31
24.06.25
24.06.25
20.84%
16:35
16:35
G1 Therapeutics
Start price
Target price
Perf. (%)
€1.06
24.06.24
24.06.24
-
24.06.25
24.06.25
72.61%
24.06.24
24.06.24
Capable Management
Good culture
Could be worthwhile Investment >10% per year
Few uniques
Gamestop Corp.
Start price
Target price
Perf. (%)
€21.40
24.06.24
24.06.24
-
24.06.25
24.06.25
4.53%
07.07.24
07.07.24
Could be worthwhile Investment >10% per year
Gamestop Corp.
Start price
Target price
Perf. (%)
€21.67
24.06.24
24.06.24
-
24.06.25
24.06.25
-1.68%
19:26
19:26
Capable Management
Good culture
Could be worthwhile Investment >10% per year
No Innovation